Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$19.42

-0.47 (-2.36%)

04:55
08/16/18
08/16
04:55
08/16/18
04:55

Exelixis management to meet with Oppenheimer

Meeting to be held in San Francisco on August 16 hosted by Oppenheimer.

  • 16

    Aug

  • 12

    Sep

  • 14

    Jan

EXEL Exelixis
$19.42

-0.47 (-2.36%)

05/10/18
PIPR
05/10/18
NO CHANGE
Target $29
PIPR
Overweight
Exelixis price target lowered to $29 from $33 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target on Exelixis (EXEL) to $29 from $33 after partner Roche (RHHBY) reported the Phase 3 IMblaze370 trial in microsatellite stable colorectal cancer patients did not meet its overall survival primary endpoint. However, the data do not impact two ongoing Phase 3 trials of cobimetinib and Tecentriq in BRAF-mutant melanoma, said Tenthoff, who keeps an Overweight rating on Exelixis shares.
05/23/18
RBCM
05/23/18
NO CHANGE
RBCM
Exelixis shares defended at RBC Capital
05/23/18
RBCM
05/23/18
NO CHANGE
RBCM
Exelixis pullback today a buying opportunity, says RBC Capital
RBC Capital analyst Kennen MacKay attributes the selloff today in shares of Exelixis to April total prescription data from Symphony. The analyst notes, however, that his analysis indicates the Symphony totals for April are well below those of IMS, implying prescription declines from March to April are not seen in IMS data. While the flat month-to-month growth from may be viewed as concerning for Cabo's continued uptake in first-line renal cell carcinoma post approval and launch of competitor Opdivo plus Yervoy in mid-April, March represented an "especially strong month," MacKay tells investors in a research note. He remains a buyer of Exelixis shares on today's weakness.
07/11/18
PIPR
07/11/18
NO CHANGE
Target $29
PIPR
Overweight
Exelixis recent weakness a buying opportunity, says Piper Jaffray
After surveying 26 medical oncologists who treat metastatic renal cell carcinoma to gauge the use of Cabometyx and immuno-oncology agents, Piper Jaffray analyst Edward Tenthoff recommends using the recent weakness in shares of Exelixis as a buying opportunity. Not surprisingly, 92% of respondents plan to begin prescribing Opdivo plus Yervoy since approval in April, Tenthoff tells investors in a research note. The analyst, however, is encouraged that 92% of the oncologists surveyed also plan to maintain or increase Cabometyx use in the first-line representing growth opportunity. In addition, Cabometyx is clearly the tyrosine kinase inhibitor of choice in the second-line, the analyst adds. He reiterates an Overweight rating on Exelixis with a $29 price target. Tenthoff believes the survey supports his 2018 Cabometyx sales forecast of $538M.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$39.76

5.37 (15.62%)

16:17
04/23/19
04/23
16:17
04/23/19
16:17
Periodicals
Twitter CEO to have 'closed-door meeting' with President Trump, Motherboard says »

Twitter CEO Jack Dorsey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

HXL

Hexcel

$69.67

1.4 (2.05%)

16:17
04/23/19
04/23
16:17
04/23/19
16:17
Earnings
Hexcel backs FY19 adj. EPS view of $3.38-$3.52, consensus $3.46 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

  • 05

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
04/23/19
04/23
16:17
04/23/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$45.43

0.24 (0.53%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Hot Stocks
MetLife raises quarterly dividend by 4.8% to 44c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 11

    Jun

  • 18

    Jun

  • 18

    Jun

MRCY

Mercury Systems

$71.81

1.38 (1.96%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Hot Stocks
Mercury Systems receives $9M follow-on order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 05

    Jun

RHI

Robert Half

$68.83

1.46 (2.17%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Earnings
Robert Half reports Q1 EPS 93c, consensus 95c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 22

    May

EBAY

eBay

$36.66

0.51 (1.41%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Earnings
eBay sees Q2 adjusted EPS 61c-63c, consensus 60c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

HXL

Hexcel

$69.67

1.4 (2.05%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Earnings
Hexcel reports Q1 EPS 84c, consensus 78c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

  • 05

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
04/23/19
04/23
16:16
04/23/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSS

TSYS

$102.25

1.46 (1.45%)

16:15
04/23/19
04/23
16:15
04/23/19
16:15
Earnings
TSYS reports Q1 adjusted EPS $1.20, consensus $1.16 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 02

    May

EBAY

eBay

$36.66

0.51 (1.41%)

16:15
04/23/19
04/23
16:15
04/23/19
16:15
Earnings
eBay reports Q1 adjusted EPS 67c, consensus 63c »

Reports Q1 revenue $2.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WNEB

Western New England Bancorp

$9.50

-0.13 (-1.35%)

16:14
04/23/19
04/23
16:14
04/23/19
16:14
Earnings
Western New England Bancorp reports Q1 EPS 13c, consensus 13c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

HAFC

Hanmi Financial

$22.53

0.94 (4.35%)

16:14
04/23/19
04/23
16:14
04/23/19
16:14
Hot Stocks
Hanmi Financial board appoints Bonnie Lee as CEO upon C. G. Kum retirement »

C. G. Kum, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 22

    May

SNAP

Snap

$12.02

0.49 (4.25%)

16:13
04/23/19
04/23
16:13
04/23/19
16:13
Hot Stocks
Snap reports Q1 free cash flow ($78M) »

Operating cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

KHC

Kraft Heinz

$33.10

0.205 (0.62%)

, CAG

Conagra Brands

$30.89

0.01 (0.03%)

16:13
04/23/19
04/23
16:13
04/23/19
16:13
Periodicals
Kraft Heinz hires Evercore to sell Ore-Ida brand, CNBC reports »

Kraft Heinz has hired…

KHC

Kraft Heinz

$33.10

0.205 (0.62%)

CAG

Conagra Brands

$30.89

0.01 (0.03%)

LW

Lamb Weston

$69.48

0.61 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

SYNL

Synalloy

$14.34

0.215 (1.52%)

16:12
04/23/19
04/23
16:12
04/23/19
16:12
Hot Stocks
Privet Management offers to acquire Synalloy for $20 per share in cash »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

SNAP

Snap

$12.03

0.5 (4.34%)

16:12
04/23/19
04/23
16:12
04/23/19
16:12
Earnings
Snap sees Q2 revenue $335M-$360M, consensus $348.04M »

Sees Q2 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SYK

Stryker

$186.51

4.465 (2.45%)

16:12
04/23/19
04/23
16:12
04/23/19
16:12
Earnings
Stryker sees Q2 adjusted EPS $1.90-$1.95, consensus $1.96 »

If foreign currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

  • 08

    May

  • 29

    May

ARAY

Accuray

$4.43

0.26 (6.24%)

16:12
04/23/19
04/23
16:12
04/23/19
16:12
Earnings
Accuray sees FY19 product revenue up 4%-8% »

Sees FY19 service revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

HAFC

Hanmi Financial

$22.57

0.98 (4.54%)

16:12
04/23/19
04/23
16:12
04/23/19
16:12
Earnings
Hanmi Financial reports Q1 EPS 48c, consensus 48c »

Total assets were $5.57…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 22

    May

SNAP

Snap

$12.03

0.5 (4.34%)

16:11
04/23/19
04/23
16:11
04/23/19
16:11
Earnings
Snap reports Q1 adjusted EPS (10c), consensus (12c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

ARAY

Accuray

$4.42

0.245 (5.88%)

16:10
04/23/19
04/23
16:10
04/23/19
16:10
Earnings
Accuray reports Q1 EPS (1c), consensus (4c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SYK

Stryker

$186.49

4.445 (2.44%)

16:10
04/23/19
04/23
16:10
04/23/19
16:10
Earnings
Stryker sees FY19 adjusted EPS $8.05-$8.20, consensus $8.13 »

Sees FY19 organic net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

  • 08

    May

  • 29

    May

EBSB

Meridian Bancorp

$16.68

0.26 (1.58%)

16:10
04/23/19
04/23
16:10
04/23/19
16:10
Earnings
Meridian Bancorp reports Q1 EPS 29c, consensus 28c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 29

    May

MANH

Manhattan Associates

$61.09

0.92 (1.53%)

16:10
04/23/19
04/23
16:10
04/23/19
16:10
Earnings
Manhattan Associates raises FY19 EPS view to $1.42-$1.46, consensus $1.40 »

Raises FY 19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 14

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.